Dianthus Therapeutics, Inc. (DNTH)

Dianthus Therapeutics Revenue

Dianthus Therapeutics had revenue of $193.00K in the quarter ending June 30, 2025, a decrease of -89.64%. This brings the company's revenue in the last twelve months to $4.85M, up 17.87% year-over-year. In the year 2024, Dianthus Therapeutics had annual revenue of $6.24M with 120.63% growth.

• Revenue (ttm): $4.85M
• Revenue Growth: +17.87%
• P/S Ratio: 147.35
• Revenue / Employee: $62,231
• Employees: 78
• Market Cap: 658.25M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.24M	3.41M	120.63%
Dec 31, 2023	2.83M	-3.59M	-55.96%
Dec 31, 2022	6.42M	4.94M	334.76%
Dec 31, 2021	1.48M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.